Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1991 Jul;64(1):108-13.
doi: 10.1038/bjc.1991.251.

Comparative pathology of breast cancer in a randomised trial of screening

Affiliations
Free PMC article
Clinical Trial

Comparative pathology of breast cancer in a randomised trial of screening

T J Anderson et al. Br J Cancer. 1991 Jul.
Free PMC article

Abstract

In the Edinburgh Randomised Breast Screening Project (EBSP) to December 1988 there were 500 cancers in the study population invited to screening and 340 cancers identified in the control population. The size and negative lymph node status characteristics of invasive cancers from the two populations were significantly different (P less than 0.05). The cancers detected by screening were predominantly 'early stage', with 16% noninvasive (PTIS) and 42% invasive stage I (pT1 node negative), whereas cancers were frequently 'late stage' (more than pT2) and inoperable in nonattenders (44%) and controls (36%). Grouped according to customary size ranges of invasive cancers, the proportion of cases lymph node positive differed in those screen detected compared with controls, but the benefit in favour of screen detection was not constant. In comparisons of cancers detected at prevalence and incidence screens, as a test of conformity with screening theory, no significant differences were apparent according to size and lymph node status, yet the characteristics of histological type of cancer discriminated significantly (P less than 0.05). When these same histological characteristics were used to compare survival, the capacity to separate invasive cancers into two groups having good and poor survival probabilities was evident, with a significant improvement for the screen detected poor survival group compared with controls (P less than 0.05).

PubMed Disclaimer

References

    1. Lancet. 1986 Mar 8;1(8480):519-23 - PubMed
    1. Cancer. 1977 Jun;39(6 Suppl):2772-82 - PubMed
    1. Int J Cancer. 1986 Oct 15;38(4):501-4 - PubMed
    1. J Clin Oncol. 1989 Sep;7(9):1239-51 - PubMed
    1. Cancer. 1989 Sep 1;64(5):1074-81 - PubMed

Publication types